Quercetin protects against ox‑LDL‑induced injury via regulation of ABCAl, LXR‑α and PCSK9 in RAW264.7 macrophages

Molecular Medicine Reports
Shanshan LiSan Li Xing

Abstract

Quercetin is a flavonoid that has anti‑inflammatory, anti‑oxidant and lipid metabolic effects. It has also been reported to reduce the risk of cardiovascular disease. The present study measured the effects of quercetin on the expression of ATP‑binding cassette transporter 1 (ABCAl), ATP‑binding cassette sub‑family G member 1 (ABCG1), liver X receptor‑α (LXR‑α), proprotein convertase subtilisin/kexin type 9 (PCSK9), p53, p21 and p16 induced by oxidized low density lipoprotein (ox‑LDL). RAW264.7 macrophages were exposed to ox‑LDL with or without 20 µmol/l quercetin and cell proliferation and senescence were quantified using β‑gal staining. Superoxide dismutase (SOD), malondialdehyde (MDA) and lipid droplets were measured in the cytoplasm using oil red staining, while intracellular and total cholesterol (TC) were measured using filipin staining and a TC kit. Immunofluorescent studies and western blot analysis were performed to quantify the expression of ABCAl, ABCG1, LXR‑α, PCSK9, p53, p21 and p16. Quercetin increased RAW264.7 cell viability and reduced lipid accumulation, senescence, lipid droplets, intracellular cholesterol and TC. It was concluded that quercetin inhibits ox‑LDL‑induced lipid droplets in RAW264.7 cells by upregu...Continue Reading

References

Apr 7, 2010·Progress in Lipid Research·Maaike H OosterveerFolkert Kuipers
May 11, 2010·Journal of Lipid Research·Mali LiuCelina V Zerbinatti
Apr 16, 2011·Current Opinion in Lipidology·Anne K Soutar
Jul 24, 2012·Biochemistry. Biokhimii︠a︡·V S RomanovT V Pospelova
Aug 8, 2012·The Journal of Pharmacology and Experimental Therapeutics·Oscar J Lara-GuzmanJose R Ramirez-Pineda
Jan 29, 2013·Biochemical and Biophysical Research Communications·Eui-Baek ByunEui-Hong Byun
Jun 21, 2013·Clinica Chimica Acta; International Journal of Clinical Chemistry·Xiao-Hua YuChao-Ke Tang
Oct 15, 2014·Current Pharmaceutical Design·Raul C Maranhao, Antonio C A Leite
Nov 2, 2014·BioFactors·Shuhui Wang, Jonathan D Smith
Jan 8, 2017·Journal of Cellular Physiology·Francesco PaciulloMatteo Pirro
Apr 22, 2017·Current Cardiology Reports·Kavita Sharma, Ragavendra R Baliga

❮ Previous
Next ❯

Citations

Jan 10, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Claudio PirozziRosaria Meli
Jun 23, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Qian DengJingui Xue
May 21, 2020·Nutrients·Maria Pia AdorniNicola Ferri
Jan 10, 2020·Oxidative Medicine and Cellular Longevity·Giorgio AquilaPaola Rizzo
Apr 17, 2021·Frontiers in Cardiovascular Medicine·Olina DagherMichel Carrier

❮ Previous
Next ❯

Methods Mentioned

BETA
protein assay
MDA

Software Mentioned

SPSS17
ImageJ

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.